C. Rogé
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Venous Thromboembolism Diagnosis and Management 3
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Global Cancer Incidence and Screening 1
- Co-authors
- Mohamed Amine Hamidou (1 shared paper)J Barrier (1 shared paper)Angelo Testa (1 shared paper)Vincent L.M. Esnault (1 shared paper)Philippe Lesavre (1 shared paper)MARIE A. P. AUDRAIN (1 shared paper)Richard Sesboüé (1 shared paper)Françis Couturaud (3 shared papers)
In The Last Decade
C. Rogé
14 papers receiving 530 citations
C. Rogé's Hit Papers
Peers
Comparison fields: 5 of 50
- Internal Medicine 74
- Oncology 204
- Pulmonary and Respiratory Medicine 185
- Cancer Research 28
- Rheumatology 20
Countries citing papers authored by C. Rogé
This map shows the geographic impact of C. Rogé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rogé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rogé more than expected).
Fields of papers citing papers by C. Rogé
This network shows the impact of papers produced by C. Rogé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rogé. The network helps show where C. Rogé may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Rogé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 237 | |
| 2 | 1993 | 181 | |
| 3 | Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial Hit paper breakdown → | 2025 | 41 |
| 4 | 2018 | 27 | |
| 5 | 2017 | 24 | |
| 6 | 2002 | 18 | |
| 7 | 2006 | 16 | |
| 8 | [Intrathoracic chemodectoma. 2 new cases]. | 1986 | 2 |
| 9 | 2019 | 2 | |
| 10 | 1991 | 1 | |
| 11 | DEFICIT EN ALPHA-UN-ANTITRYPSINE ET VASCULARITES SYSTEMIQUES : DONNEES COMPLEMENTAIRES | 1994 | 1 |
| 12 | Mal de Pott | 1997 | 1 |
| 13 | Safety of immune checkpoint inhibitors for the treatment of melanoma, bronchopulmonary and urologic neoplasms in patients with preexisting autoimmune disease | 2017 | 1 |
| 14 | 2018 | 1 |
About C. Rogé
C. Rogé is a scholar working on Internal Medicine, Oncology, Pulmonary and Respiratory Medicine, Surgery and Economics and Econometrics, having authored 14 papers that have together received 553 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (3 papers), Vasculitis and related conditions (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Adrenal and Paraganglionic Tumors (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Global Cancer Incidence and Screening (1 paper), Occupational and environmental lung diseases (1 paper) and Economic and Financial Impacts of Cancer (1 paper). The work is most often cited by research in Internal Medicine (74 citations), Oncology (204 citations), Pulmonary and Respiratory Medicine (185 citations), Cancer Research (28 citations) and Rheumatology (20 citations). C. Rogé has collaborated with scholars based in France and Belgium. Frequent co-authors include Mohamed Amine Hamidou, J Barrier, Angelo Testa, Vincent L.M. Esnault, Philippe Lesavre, MARIE A. P. AUDRAIN, Richard Sesboüé, Françis Couturaud, Christophe Leroyer and Florence Jego. Their work appears in journals such as Lung Cancer, Thrombosis and Haemostasis, The Lancet, Clinical Genetics and Journal of Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.